Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL

Yücel Erbilgin, Sinem Firtina, PhD, Ozden Hatirnaz Ng, PhD, Tiraje Celkan, MD, Zeynep Karakas, MD, Seniye Sema Anak, MD, Nazan Sarper, MD, Emine Zengin, MD, Ahmet Eskazan, MD, Muge Sayitoglu, PhD, Ugur Ozbek, MD, PhD

Blood (2017) 130 (Supplement 1): 5110.

https://doi.org/10.1182/blood.V130.Suppl_1.5110.5110

Published: 2017

Journal Articles

Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study

Yesim Aydinok, MD, Zeynep Karakas, MD, Elena Cassinerio, MD, Noppadol Siritanaratkul, MD, Antonis Kattamis, MD, Aurelio Maggio, MD, Norbert Hollaender, PhD, Bruyère Mahuzier, Pharm D, Brian Gadbaw, MD, Ali T. Taher, MD PhD

Blood (2016) 128 (22): 852.

https://doi.org/10.1182/blood.V128.22.852.852

Published: 2016

Journal Articles

Deferasirox–Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload (HYPERION)

Yesim Aydinok, MD, Antonis Kattamis, MD, M Domenica Cappellini, MD, Amal El-Beshlawy, MD, Raffaella Origa, MD, Mohsen Elalfy, MD, Yurdanur Kilinç, MD, Silverio Perrotta, MD, Zeynep Karakas, MD, Vip Viprakasit, MD, Dany Habr, MD, Antje Wegener, MD, Junwu Shen, PhD, John B Porter, MD

Blood (2013) 122 (21): 2257.

https://doi.org/10.1182/blood.V122.21.2257.2257

Published: 2013

Journal Articles

Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

Yucel Erbilgin, Ozden Hatirnaz Ng, PhD, Sinem Firtina, Tiraje Celkan, Sema Anak, MD, Zeynep Karakas, MD, Aykan Ozguven, MD, Nazan Sarper, MD, Emine Zengin, MD, Emine Turkkan, MD, Didem Yalcin Atay, MD, Yuk Yin Ng, PhD, Omer Dogru, MD, Muge Sayitoglu, PhD, Ugur Ozbek

Blood (2013) 122 (21): 1380.

https://doi.org/10.1182/blood.V122.21.1380.1380

Published: 2013

Journal Articles

Deferasirox Continues to Reduce Iron Overload in Non-Transfusion-Dependent Thalassemia: A One-Year, Open-Label Extension to a One-Year, Randomized, Double-Blind, Placebo-Controlled Study (THALASSA)

Ali T Taher, MD, John B Porter, MD, Vip Viprakasit, MD, DPhil, Antonis Kattamis, MD, Suporn Chuncharunee, MD, Pranee Sutcharitchan, MD, Noppadol Siritanaratkul, MD, Renzo Galanello, MD, Zeynep Karakas, MD, Tomasz Lawniczek, MD, Dany Habr, MD, Jacqueline Ros, PhD, Zewen Zhu, M Domenica Cappellini, MD

Blood (2012) 120 (21): 3258.

https://doi.org/10.1182/blood.V120.21.3258.3258

Published: 2012

Journal Articles

Frequency of Agranulocytosis and Mild Neutropenia During Deferiprone Therapy in Clinical Practice

Mohsen Saleh Elalfy, MD, Shebl Said Shebl, MD, Mohamed A. Badr, MD, Prof, Usama R. Elsafy, MD, Prof, Mostafa A. Salama, MD, Prof, Youssef Al-Tonbary, MD, Yousryeia Abdel Rahman, MD, Mohamad H. Qari, MD, Ghazi Abdullah Al Damnhouri, MD, Zakaria Al Hawsawi, MD, Yasser Ahmed Wali, MD, Prof, M. Akif Yesilipek, MD, Prof, Yurdanur Kilinc, MD, Dilek Yazman, MD, Zeynep Karakas, MD, Fernando Tricta, MD

Blood (2012) 120 (21): 996.

https://doi.org/10.1182/blood.V120.21.996.996

Published: 2012

Journal Articles

Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study

Ali T Taher, MD, John B. Porter, MD, Vip Viprakasit, MD; DPhil, Antonis Kattamis, MD, Suporn Chuncharunee, MD, Pranee Sutcharitchan, MD, Noppodol Siritanaratkul, MD, Renzo Galanello, MD, Zeynep Karakas, MD, Tomasz Lawniczek, MD, Jacqueline Ros, PhD, Yiyun Zhang, Dany Habr, MD, M. Domenica Cappellini, MD

Blood (2011) 118 (21): 902.

https://doi.org/10.1182/blood.V118.21.902.902

Published: 2011

Journal Articles

Plasminogen Activator Inhibitor-1 and Vitronectin Levels in Children with Acute Lymphoblastic Leukemia, and Their Relationship with Risk Groups

Semra Ayduran, Omer Devecioglu, Aysegul Unuvar, Hakan Ekmekci, Zeynep Karakas, MD, Gulyuz Ozturk, Sema Anak, Leyla Agaoglu, MD, Kaan Kavakli, MD

Blood (2011) 118 (21): 4365.

https://doi.org/10.1182/blood.V118.21.4365.4365

Published: 2011

Journal Articles

Congenital Erythropoietic Porphyria Due to Co-Inheritance of GATA1 and UROS Gene Mutations

Zeynep Karakas, MD, Chiara Refaldi, Valentina Brancaleoni, Ismail Kurt, MD, Elena Di Pierro, PhD, Maria Domenica Cappellini, MD

Blood (2010) 116 (21): 3208.

https://doi.org/10.1182/blood.V116.21.3208.3208

Published: 2010

Journal Articles

Defective NATURAL Killer ACTIVITY Improved by IL-2 Stimulation Independent of CD16 and NKG2D Receptors IN PATIENTS with THALASSEMIA MAJOR.

Zeynep Karakas, MD

Blood (2009) 114 (22): 4746.

https://doi.org/10.1182/blood.V114.22.4746.4746

Published: 2009

Journal Articles

Correlation Between Defective NK Activity and Low Expression of CD16, NKp44 and NKG2D in Beta Thalassemia Patients

Belkis Atasever, MSc, Serap Erdem Kuruca, PhD, Zeynep Karakas, MD, Batu Erman, PhD, Arzu Ergen, PhD, Turgay Isbir, PhD

Blood (2008) 112 (11): 5425.

https://doi.org/10.1182/blood.V112.11.5425.5425

Published: 2008

Journal Articles

The Antileukemic Potential of New Derivatives of 5-Fluoro-1H-Indole-2,3-Dione-3-Thiosemicarbazone on in Vitro Cell Lines

Serap Erdem Kuruca, PhD, Nilgun Karali, PhD, Beyza Cetin, MSc, Sabriye Karadenizli, MSc, Zeynep Karakas, MD

Blood (2008) 112 (11): 5055.

https://doi.org/10.1182/blood.V112.11.5055.5055

Published: 2008

NARROW

IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL

Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study

Deferasirox–Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload (HYPERION)

Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

Deferasirox Continues to Reduce Iron Overload in Non-Transfusion-Dependent Thalassemia: A One-Year, Open-Label Extension to a One-Year, Randomized, Double-Blind, Placebo-Controlled Study (THALASSA)

Frequency of Agranulocytosis and Mild Neutropenia During Deferiprone Therapy in Clinical Practice

Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study

Plasminogen Activator Inhibitor-1 and Vitronectin Levels in Children with Acute Lymphoblastic Leukemia, and Their Relationship with Risk Groups

Congenital Erythropoietic Porphyria Due to Co-Inheritance of GATA1 and UROS Gene Mutations

Defective NATURAL Killer ACTIVITY Improved by IL-2 Stimulation Independent of CD16 and NKG2D Receptors IN PATIENTS with THALASSEMIA MAJOR.

Correlation Between Defective NK Activity and Low Expression of CD16, NKp44 and NKG2D in Beta Thalassemia Patients

The Antileukemic Potential of New Derivatives of 5-Fluoro-1H-Indole-2,3-Dione-3-Thiosemicarbazone on in Vitro Cell Lines

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only